Document Detail


The effects of biofeedback in diabetes and essential hypertension.
MedLine Citation:
PMID:  20622080     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The metabolic syndrome is likely to develop in patients in whom genetic predisposition, chronic stress, negative emotion, and unhealthy lifestyle habits converge. In light of the psychophysiologic aspect of most of these factors, biofeedback, relaxation, and other psychophysiologic interventions have been studied and used in patients with elements of the metabolic syndrome, particularly diabetes and hypertension. This article reviews the rationale and evidence for biofeedback for the treatment of diabetes and hypertension, which has been shown to effectively lower blood glucose and blood pressure in numerous studies. Patients with prehypertension may be a particularly appropriate target population for biofeedback for blood pressure reduction. Further research is needed to guide identification of the best candidates for psychophysiologic intervention for these conditions, although patient readiness for change is a clear prerequisite.
Authors:
Angele McGrady
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  77 Suppl 3     ISSN:  1939-2869     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S68-71     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, University of Toledo, Toledo, OH 43614-2598, USA. angele.mcgrady@utoledo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biofeedback in the treatment of epilepsy.
Next Document:  Depression and heart failure: an overview of what we know and don't know.